Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)
Key facts
- Where
- Herlev, DenmarkSee the site
Where in Denmark
- University Hospital HerlevHerlev, DenmarkNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Copenhagen University Hospital at Herlev
- Trial code
- NCT06802991
- Record updated
- 21 October 2026
- Original description
The purpose of the study is to investigate whether an extended program (ERAS 3.0) initiated hospital discharge, can improve recovery in elderly, frail patients who have undergone surgery for colon cancer.Read full original descriptionShow less
The purpose of the study is to investigate whether an extended program (ERAS 3.0) initiated hospital discharge, can improve recovery in elderly, frail patients who have undergone surgery for colon cancer.
The study is a randomised controlled trial with two groups: an intervention group receiving the ERAS 3.0 program and a control group recieving standard care. The ERAS 3.0 program includes a comprehensive geriatric health assessment, dietary counseling from a dietitian, and instructions on training and physical activity. These activities will take place in the participant's homes after hospital discharge. Data will be collected at multiple time points: at the hospital, 12 days post-discharge (at the outpatient clinic), and at 1 and 3 months post discharge in the participants' homes.
Inclusion: Clinical Frailty Scale preoperative score 4-7 or G8 score ≤ 14; Nutritional Risk Screening tool (NRS 2002) > 3; Elective colonic or rectal resection; Minimally invasive surgical approach (laparoscopic or robotic); Patients discharged to own home; Informed consent to participate.
Exclusion: Major complications following surgery (Clavien-Dindo >3a); Known food allergies to dairy or any other ingredient contained in the nutrition package; All conditions including psychological, geographical, and social factors that could hinder adherence to the trial protocol; Conversion to laparotomy; Participation in other randomised trials in conflict with the protocol and end- points of the ERAS 3.0 project; Discharged with tube feeding and parenteral nutrition (partially or completely); Incapable of providing informed consent; Discharge to 24-hour municipal rehabilitation facility.